Progress in Mind
Choose a channel
Check out the different Progress in Mind content channels.
Progress in Mind Resource Center reports from the 32nd World Congress of Neuropsychopharmacology.
The Progress in Mind Resource Center brings you the latest science from the CINP Congress 2021. Our team of reporters is online to capture some of the best content from the virtual Congress just for you:
- Updates on the latest research in Psychiatry
- Summaries from key sessions during the Congress
Stay tuned as we bring you the latest from CINP 2021!
Schizophrenia
Read time: 3 min Congress highlights
Is highly potent cannabis driving first episode psychosis?
Regular use of potent cannabis is strongly linked to the incidence of psychosis, according to...
Schizophrenia
Read time: 3 min Congress highlights
Debate continues over long-term antipsychotic use
Care in choice of agent, caution in efforts to discontinue therapy and the need for more studies...
Depression
Read time: 3 min Congress highlights
5-HT2A receptor PET, functional MRI and serotonin: happy together?
The first direct evidence of an intrinsic serotonin deficit in the brains of people with major...
Depression
Read time: 2 min Congress highlights
Melancholic MDD: different presentation and treatment but same response
Even if melancholic features represent more severe depression, clinicians seem to have developed...
Depression
Read time: 2 min Congress highlights
Melancholic MDD: different presentation and treatment but same response
Even if melancholic features represent more severe depression, clinicians seem to have developed...
Bipolar, Schizophrenia
Read time: 2 min Congress highlights
Do similar polygenic risk factors for schizophrenia apply across ethnic groups?
Polygenic risk factors for schizophrenia and bipolar disorder-- and the genetic factors that...
Mental health
Read time: 2 min Congress highlights
Partial dopamine agonists: wide spectrum of activity and indications
Dopamine partial agonists decrease transmission when there is excess of the neurotransmitter, but...
Depression, Alzheimer's Disease
Read time: 2 min Congress highlights
Memory deficits and β-amyloid prominent in elderly with treatment-resistant depression
Elderly patients with treatment-resistant depression have greater cognitive deficits and more brain...
Bipolar
Read time: 3 min Satellite symposium
Can early intervention prevent progressive loss of brain and cognitive capacity?
Given imaging and cognitive science evidence that bipolar disorder is neuroprogressive, early...
Depression
Read time: 2 min Satellite symposium
Neurobiological insights into depression and treatment resistance
Neuroplasticity, synaptic dysfunction, and activation of the HPA axis are among areas of active...
Depression
Read time: 2 min Congress highlights
Social isolation- a portal to pathology
Social isolation, of the kind made worse by COVID-19, affects many systems relevant to mental...
Schizophrenia
Read time: 2 min Satellite symposium
Early onset schizophrenia needs patient-specific management
Early diagnosis and effective, well-tolerated treatment of early-onset schizophrenia are crucial to...